115 related articles for article (PubMed ID: 6884362)
1. Evidence for preferential proteolytic cleavage of one of the two fibronectin subunits and for immunological localization of a site distinguishing them.
Vartio T; Barlati S; de Petro G; Miggiano V; Stähli C; Takács B; Vaheri A
Eur J Biochem; 1983 Sep; 135(2):203-7. PubMed ID: 6884362
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody against the N-terminal end of human plasma fibronectin.
Vartio T; Salonen EM; De Petro G; Barlati S; Miggiano V; Stähli C; Virgallita G; Takács B; Vaheri A
Biochem J; 1983 Oct; 215(1):147-51. PubMed ID: 6194791
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies in analysis of cathepsin G-digested proteolytic fragments of human plasma fibronectin.
Vartio T; Zardi L; Balza E; Towbin H; Vaheri A
J Immunol Methods; 1982 Dec; 55(3):309-18. PubMed ID: 7166647
[TBL] [Abstract][Full Text] [Related]
4. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
Click EM; Balian G
Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
[TBL] [Abstract][Full Text] [Related]
5. Early and late cathepsin D-derived fragments of fibronectin containing the C-terminal interchain disulfide cross-link.
Richter H; Hörmann H
Hoppe Seylers Z Physiol Chem; 1982 Apr; 363(4):351-64. PubMed ID: 7076131
[TBL] [Abstract][Full Text] [Related]
6. Location of heparin-binding sites of fibronectin. Detection of a hitherto unrecognized transamidase sensitive site.
Richter H; Seidl M; Hörmann H
Hoppe Seylers Z Physiol Chem; 1981 Apr; 362(4):399-408. PubMed ID: 7239439
[TBL] [Abstract][Full Text] [Related]
7. Characterization of porcine plasma fibronectin and its fragmentation by porcine liver cathepsin B.
Isemura M; Yosizawa Z; Takahashi K; Kosaka H; Kojima N; Ono T
J Biochem; 1981 Jul; 90(1):1-9. PubMed ID: 6457032
[TBL] [Abstract][Full Text] [Related]
8. Transformation-enhancing activity of gelatin-binding fragments of fibronectin.
De Petro G; Barlati S; Vartio T; Vaheri A
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4965-9. PubMed ID: 6458038
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding domains in the fragments cleaved by cathepsin G from human plasma fibronectin.
Vartio T
Eur J Biochem; 1982 Apr; 123(2):223-33. PubMed ID: 7075587
[No Abstract] [Full Text] [Related]
10. Characterization of the opsonic and monocyte adherence functions of the specific fibronectin fragment that enhances phagocytosis of particulate activators.
Czop JK; Kadish JL; Zepf DM; Austen KF
J Immunol; 1985 Mar; 134(3):1844-50. PubMed ID: 3968434
[TBL] [Abstract][Full Text] [Related]
11. Identification with monoclonal antibodies of different regions of human plasma fibronectin, including that which interacts with human monocyte fibronectin receptors.
Czop JK; Kadish JL; Zepf DM; Austen KF
Immunology; 1985 Mar; 54(3):407-17. PubMed ID: 2579023
[TBL] [Abstract][Full Text] [Related]
12. Regular fragmentation of hydrogen peroxide-treated fibronectin.
Vartio T
J Biol Chem; 1989 Mar; 264(8):4471-5. PubMed ID: 2538445
[TBL] [Abstract][Full Text] [Related]
13. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin.
Lambert Vidmar S; Lottspeich F; Emod I; Planchenault T; Keil-Dlouha V
Eur J Biochem; 1991 Oct; 201(1):71-7. PubMed ID: 1915379
[TBL] [Abstract][Full Text] [Related]
14. The mitogenic activity of a heparin-binding fibronectin fragment (Mr 35,000) produced by cathepsin D digestion.
Savill CM; Ayad SR
Anticancer Res; 1986; 6(2):321-6. PubMed ID: 3707069
[TBL] [Abstract][Full Text] [Related]
15. An amphiphilic structure of the ninth component of human complement. Evidence from analysis of fragments produced by alpha-thrombin.
Biesecker G; Gerard C; Hugli TE
J Biol Chem; 1982 Mar; 257(5):2584-90. PubMed ID: 6460761
[TBL] [Abstract][Full Text] [Related]
16. Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies.
Sekiguchi K; Siri A; Zardi L; Hakomori S
J Biol Chem; 1985 Apr; 260(8):5105-14. PubMed ID: 3988746
[TBL] [Abstract][Full Text] [Related]
17. Alignment of biologically active domains in the fibronectin molecule.
Ruoslahti E; Hayman EG; Engvall E; Cothran WC; Butler WT
J Biol Chem; 1981 Jul; 256(14):7277-81. PubMed ID: 6788765
[TBL] [Abstract][Full Text] [Related]
18. Localization of two unique heparin binding domains of human plasma fibronectin with monoclonal antibodies.
Smith DE; Furcht LT
J Biol Chem; 1982 Jun; 257(11):6518-23. PubMed ID: 6176583
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of fibronectin reactivity among streptococci as revealed by binding of fibronectin fragments.
Chhatwal GS; Blobel H
Comp Immunol Microbiol Infect Dis; 1987; 10(2):99-108. PubMed ID: 3621887
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of fibronectin with monoclonal antibodies.
Atherton BT; Taylor DM; Hynes RO
J Supramol Struct Cell Biochem; 1981; 17(2):153-61. PubMed ID: 7321057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
